HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report

References

• Adams, L. M., Balderson, B., Packett, B. J. II, Brown, K., & Catz, S. L. (2015, April). Providers’ perspectives on prescribing pre-exposure prophylaxis (PrEP) for HIV prevention. The HIV Specialist: Magazine of the American Academy of HIV Medicine, pp. 19–25.
   Google Scholar
• Arnold, E. A., Hazelton, P., Lane, T., Christopoulos, K. A., Galindo, G. R., Steward, W. T., & Morin, S. F. (2012). A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. Plos One, 7(7), e40603–e40608. doi: 10.1371/journal.pone.0040603
   PubMed Web of Science ®Google Scholar
• Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of Pre-Exposure Prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. doi: 10.1089/apc.2014.0142
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi: 10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Bogart, L. M., Catz, S. L., Kelly, J. A., & Benotsch, E. G. (2001). Factors influencing physicians’ judgments of adherence and treatment decisions for patients with HIV disease. Medical Decision Making, 21(1), 28–36. doi: 10.1177/0272989X0102100104
   PubMed Web of Science ®Google Scholar
• Calabrese, S. K., Earnshaw, V. A., Underhill, K., Hansen, N. B., & Dovidio, J. F. (2014). The impact of patient race on clinical decisions related to prescribing HIV Pre-Exposure Prophylaxis (PrEP): Assumptions about sexual risk compensation and implications for access. AIDS and Behavior, 18(2), 226–240. doi: 10.1007/s10461-013-0675-x
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2012, December). Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report, 17(4). Retrieved from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2014, May 14). Preexpsoure prophylaxis for the prevention of HIV infection in the United States – 2014 clinical practice guideline. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
   Google Scholar
• Escudero, D. J., Kerr, T., Wood, E., Nguyen, P., Lurie, M. N., Sued, O., & Marshall, B. D. L. (2015). Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) among people who inject drugs (PWID) in a Canadian setting. AIDS and Behavior, 19(5), 752–757. doi: 10.1007/s10461-014-0867-z
   PubMed Web of Science ®Google Scholar
• Fleishman, J. A., Yehia, B. R., Moore, R. D., Gebo, K. A., & Agwu, A. L. (2012). Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002–2008). Medical Care, 50(5), 419–427. doi: 10.1097/MLR.0b013e31824e3356
   PubMed Web of Science ®Google Scholar
• Gebo, K. A., Fleishman, J. A., Conviser, R., Reilly, E. D., Korthuis, P. T., Moore, R. D., … Mathews, W. C. (2005). Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. JAIDS, 38(1), 96–103.
   Google Scholar
• Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829. doi: 10.1016/S1473-3099(14)70847-3
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599. doi: 10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• IBM Corporation (2013). IBM SPSS Statistics for Windows (version 22.0). Armonk, NY: IBM Corporation.
   Google Scholar
• Karris, M. Y., Beekmann, S. E., Mehta, S. R., Anderson, C. M., & Polgreen, P. M. (2013). Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clinical Infectious Diseases, 58(5), 704–712. doi: 10.1093/cid/cit796
   PubMed Web of Science ®Google Scholar
• Krakower, D., Ware, N., Mitty, J. A., Maloney, K., & Mayer, K. H. (2014). HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: A qualitative study. AIDS and Behavior, 18, 1712–1721. doi: 10.1007/s10461-014-0839-3
   PubMed Web of Science ®Google Scholar
• Krakower, D. S., Beekman, S. E., Polgreen, P. M., & Mayer, K. H. (2015). Diffusion of newer HIV prevention innovations: Variable practices of frontline infectious diseases physicians. Clinical Infectious Diseases. Advance online publication. doi:10.1093/cid/civ736
   Google Scholar
• Stein, M., Thurmond, P., & Bailey, G. (2014). Willingness to use HIV Pre-Exposure Prophylaxis among opiate users. AIDS and Behavior, 18, 1694–1700. doi: 10.1007/s10461-014-0778-z
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367, 423–434. doi: 10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar